This is a delivery order awarded by the Medical Supply Chain branch of the Department of Defense's Defense Logistics Agency (DLA) to Mckesson Corporation, doing business as Mckesson Drug Company, on February 25, 2016. The $341,954.65 firm fixed price contract is for the delivery of unspecified pharmaceutical products to military treatment facilities. The contract has no set-aside designation and is associated with Mckesson's existing role as a prime vendor for the Department of Veterans Affairs and Indian Health Service, providing over $5.8 million in pharmaceutical products such as penicillin injections and alvimopan capsules. Mckesson also holds a $675 million National Supply Service Center prime vendor blanket purchase agreement with the Indian Health Service to furnish pharmaceutical supplies, as well as a $710 million single-award blanket purchase agreement valid through 2025 to provide the Indian Health Service with essential medical supplies.